Thioguanil: an antimetabolite drug, a purine analogue.
The drug is a product of domestic manufacturers GNIISKLS (Russia). International name - Thioguanila.
Thioguanil has a wide range of indications for use in the following conditions: acute and chronic forms of myeloid leukemia (acute, undifferentiated, chronic myeloid), lymphoid leukemia. The drug is contraindicated in case of certain abnormalities in the functioning of internal organs, for example, bone marrow suppression. He